J&J/Merck Pepcid AC Orally Disintegrating Tablets In The Works
J&J/Merck is looking to extend its category-leading Pepcid AC franchise with an orally disintegrating dosage form developed by Yamanouchi Pharma Technologies.
J&J/Merck is looking to extend its category-leading Pepcid AC franchise with an orally disintegrating dosage form developed by Yamanouchi Pharma Technologies.